IL155997A0 - Protease inhibitors - Google Patents

Protease inhibitors

Info

Publication number: IL155997A0
Authority: IL; Israel
Prior art keywords: protease inhibitors; protease; inhibitors
Prior art date: 2000-11-22

Application number

IL15599701A

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-22

Filing date

2001-11-19

Publication date

2003-12-23

2001-11-19 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2003-12-23 Publication of IL155997A0 publication Critical patent/IL155997A0/en

Links

229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
239000000137 peptide hydrolase inhibitor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

IL15599701A 2000-11-22 2001-11-19 Protease inhibitors IL155997A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US25250800P	2000-11-22	2000-11-22
PCT/US2001/051647 WO2003053331A2 (en)	2000-11-22	2001-11-19	Protease inhibitors

Publications (1)

Publication Number	Publication Date
IL155997A0 true IL155997A0 (en)	2003-12-23

Family

ID=22956303

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL15599701A IL155997A0 (en)	2000-11-22	2001-11-19	Protease inhibitors

Country Status (17)

Country	Link
EP (1)	EP1392657A4 (en)
JP (1)	JP2005513083A (en)
KR (1)	KR20040004445A (en)
CN (1)	CN1635903A (en)
AR (1)	AR034278A1 (en)
AU (1)	AU2001298052A1 (en)
BR (1)	BR0115473A (en)
CA (1)	CA2436850A1 (en)
CZ (1)	CZ20031403A3 (en)
HU (1)	HUP0301964A3 (en)
IL (1)	IL155997A0 (en)
MX (1)	MXPA03004542A (en)
NO (1)	NO20032328L (en)
PL (1)	PL366232A1 (en)
UY (1)	UY27032A1 (en)
WO (1)	WO2003053331A2 (en)
ZA (1)	ZA200303848B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030144175A1 (en)	1998-12-23	2003-07-31	Smithkline Beecham Corporation	Protease inhibitors
AU4344101A (en)	2000-03-21	2001-10-03	Smithkline Beecham Corp	Protease inhibitors
HUP0301231A2 (en) *	2000-06-14	2003-08-28	Smithkline Beecham Corp.	Protease inhibitors, pharmaceutical compositions containing them and their use
KR20100023948A (en)	2007-06-08	2010-03-04	닛뽕 케미파 가부시키가이샤	Therapeutic or prophylactic agent for cerebral aneurysm
WO2009054454A1 (en)	2007-10-24	2009-04-30	National University Corporation Tokyo Medical And Dental University	Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TR200101869T2 (en) *	1998-12-23	2002-01-21	Smithkline Beecham Corporation	Protease Inhibitors.
AU4344101A (en) *	2000-03-21	2001-10-03	Smithkline Beecham Corp	Protease inhibitors
HUP0301231A2 (en) *	2000-06-14	2003-08-28	Smithkline Beecham Corp.	Protease inhibitors, pharmaceutical compositions containing them and their use

2001
- 2001-11-19 CN CNA018220533A patent/CN1635903A/en active Pending
- 2001-11-19 PL PL01366232A patent/PL366232A1/en not_active Application Discontinuation
- 2001-11-19 CZ CZ20031403A patent/CZ20031403A3/en unknown
- 2001-11-19 MX MXPA03004542A patent/MXPA03004542A/en unknown
- 2001-11-19 KR KR10-2003-7006807A patent/KR20040004445A/en not_active Withdrawn
- 2001-11-19 IL IL15599701A patent/IL155997A0/en unknown
- 2001-11-19 JP JP2003554091A patent/JP2005513083A/en not_active Withdrawn
- 2001-11-19 AU AU2001298052A patent/AU2001298052A1/en not_active Abandoned
- 2001-11-19 EP EP01275089A patent/EP1392657A4/en not_active Withdrawn
- 2001-11-19 BR BR0115473-7A patent/BR0115473A/en not_active Application Discontinuation
- 2001-11-19 WO PCT/US2001/051647 patent/WO2003053331A2/en not_active Ceased
- 2001-11-19 CA CA002436850A patent/CA2436850A1/en not_active Abandoned
- 2001-11-19 HU HU0301964A patent/HUP0301964A3/en unknown
- 2001-11-20 AR ARP010105409A patent/AR034278A1/en unknown
- 2001-11-21 UY UY27032A patent/UY27032A1/en not_active Application Discontinuation
2003
- 2003-05-16 ZA ZA200303848A patent/ZA200303848B/en unknown
- 2003-05-22 NO NO20032328A patent/NO20032328L/en unknown

Also Published As

Publication number	Publication date
EP1392657A2 (en)	2004-03-03
WO2003053331A2 (en)	2003-07-03
HUP0301964A3 (en)	2007-09-28
CZ20031403A3 (en)	2003-10-15
CA2436850A1 (en)	2003-07-03
NO20032328L (en)	2003-07-02
MXPA03004542A (en)	2003-09-10
JP2005513083A (en)	2005-05-12
ZA200303848B (en)	2004-06-28
CN1635903A (en)	2005-07-06
UY27032A1 (en)	2002-07-31
KR20040004445A (en)	2004-01-13
AR034278A1 (en)	2004-02-18
BR0115473A (en)	2004-09-28
EP1392657A4 (en)	2004-03-10
PL366232A1 (en)	2005-01-24
HUP0301964A2 (en)	2007-02-28
WO2003053331A3 (en)	2003-11-13
NO20032328D0 (en)	2003-05-22
AU2001298052A1 (en)	2003-07-09

Publication	Publication Date	Title
AP2002002593A0 (en)	2002-09-30	Protease inhibitors
TWI339661B (en)	2011-04-01	Peptidomimetic protease inhibitors
GB0125445D0 (en)	2001-12-12	Protease Inhibitors
IL153421A0 (en)	2003-07-06	Protease inhibitors
EP1235577A4 (en)	2003-04-09	Protease inhibitors
EP1232155A4 (en)	2002-11-20	Protease inhibitors
IL151087A0 (en)	2003-04-10	Protease inhibitors
EP1229914A4 (en)	2004-06-23	Protease inhibitors
EP1229912A4 (en)	2003-05-07	Protease inhibitors
EP1231921A4 (en)	2004-06-23	Protease inhibitors
EP1229915A4 (en)	2003-05-14	Protease inhibitors
EP1161237A4 (en)	2002-03-27	Protease inhibitors
EP1233771A4 (en)	2003-05-14	Protease inhibitors
EP1351930A4 (en)	2004-09-15	Protease inhibitors
EP1229911A4 (en)	2003-05-07	Protease inhibitors
EP1173429A4 (en)	2002-06-19	Protease inhibitors
EP1401453A4 (en)	2005-04-06	Protease inhibitors
EP1231923A4 (en)	2003-05-14	Protease inhibitors
HUP0301964A3 (en)	2007-09-28	Protease inhibitors
IL155961A0 (en)	2003-12-23	Cysteine protease inhibitors
EP1232154A4 (en)	2004-06-23	Protease inhibitors
EP1231922A4 (en)	2004-06-23	Protease inhibitors
AU6407701A (en)	2001-12-24	Serine protease inhibitors
GB0009123D0 (en)	2000-05-31	Protease inhibitor
ZA200207478B (en)	2003-10-08	Protease inhibitors.